Ruchika Chitravanshi

All stories by Ruchika Chitravanshi

How the new Companies Act will affect Tata Sons, Bharti Telecom

How the new Companies Act will affect Tata Sons, Bharti Telecom

Rediff.com6 days ago

Companies such as Tata Sons and Bharti Telecom, which are unlisted but have listed subsidiaries, may soon have to file periodic financial statements with the registrar of companies under the new provision of the Companies Act. The provision requires greater financial disclosures by a certain category of unlisted companies.

After a year of Covid, India may not face a second wave

After a year of Covid, India may not face a second wave

Rediff.com9 Feb 2021

Epidemiologists point out that if there is no second wave, it means that the number of infected has surpassed the uninfected, reports Ruchika Chitravanshi.

Despite Covid, registration of new companies went up in 2020

Despite Covid, registration of new companies went up in 2020

Rediff.com24 Jan 2021

Moreover, 5,611 companies struck off earlier by the ministry of corporate affairs because of compliance-related lacunae, were registered again.

Trusts, societies have to register with MCA by April 1

Trusts, societies have to register with MCA by April 1

Rediff.com23 Jan 2021

Corporate social responsibility rules that kicked in on Friday also set a three year time-limit for any CSR project, among a series of other amendments introduced by the government.

Covaxin has tolerable safety: Lancet

Covaxin has tolerable safety: Lancet

Rediff.com23 Jan 2021

The vaccine was well tolerated in all dose groups with no vaccine-related adverse events.

Govt proposes phase-wise pre-packed insolvency process

Govt proposes phase-wise pre-packed insolvency process

Rediff.com18 Jan 2021

A draft proposal by the sub-committee of the insolvency law committee has recommended that the corporate debtor (CD) may initiate the prepack since it may prove difficult to implement if creditors are allowed to do so without the willingness of the promoter.

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

More than 60% of bankruptcy proceedings led to liquidation in Q2

More than 60% of bankruptcy proceedings led to liquidation in Q2

Rediff.com16 Dec 2020

Experts say this further underlines the lack of investor interest in stressed assets at present.

Govt to decriminalise provisions of LLP Act

Govt to decriminalise provisions of LLP Act

Rediff.com23 Nov 2020

One of the changes being proposed is allowing LLPs to issue non-convertible debentures.

Foreign listing of start-ups, MSMEs will now be easier

Foreign listing of start-ups, MSMEs will now be easier

Rediff.com10 Nov 2020

The criteria for allowing companies to avail of this provision will include profitability, networth, paid-up capital, and turnover.

How complex is the process of getting approval for a vaccine?

How complex is the process of getting approval for a vaccine?

Rediff.com30 Sep 2020

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.

'We are moving fast towards the peak of the epidemic'

'We are moving fast towards the peak of the epidemic'

Rediff.com23 Sep 2020

Unsurprised by the rising numbers, epidemiologists are concerned about the virus reaching rural and tribal areas where the health infrastructure is weak, reports Ruchika Chitravanshi.

'Covid has not crushed demand for foreign education, it has only delayed it'

'Covid has not crushed demand for foreign education, it has only delayed it'

Rediff.com4 Sep 2020

'Students are taking a keen interest in a hybrid model, where they start classes online and then complete the course on campus.'

Companies allowed to extend AGMs by up to 3 months

Companies allowed to extend AGMs by up to 3 months

Rediff.com20 Aug 2020

Indian companies are required to hold AGMs within six months of closure of the financial year.

Swachh Bharat man, Param Iyer calls it a day as sanitation secy

Swachh Bharat man, Param Iyer calls it a day as sanitation secy

Rediff.com28 Jul 2020

Iyer, popularly called Param, is keen to return to the US where he had spent several years working with the World Bank at its Washington office -- a job he later quit to become road manager for his daughter, a professional tennis player.

India may see wave of peaks in COVID-19 cases

India may see wave of peaks in COVID-19 cases

Rediff.com20 Jul 2020

Many experts feel the concept of a national peak is nebulous, given that the growth in case numbers is dominated by a handful of states.

Where's the Covid-19 data, ask scientists

Where's the Covid-19 data, ask scientists

Rediff.com6 Jul 2020

Epidemiologists worry there's little or no data being shared on mortality by age group and contacts traced, which makes it difficult to understand how the effects of Covid-19 might be different in the Indian population, reports Ruchika Chitravanshi

Next